The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Hepatitis and HIV CoinfectionHepatitis and HIV Coinfection
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

Treatment for indian subtype hepatitis c
Dec 22, 2011

Dear Doctor, Which type of hepatitis C is most prevalent in the indian subcontinent? 1 and 3? Are these indian strains susceptible to pegylated interferon, ribavirin, boceprevir and telaprevir? What are the success rates? And what kind of HAART would you recommend for a co-infected person with HIV? What is the longevity of such co0infected patients if on proper treatment and positive lifestyle modification? Best wishes.

Response from Dr. McGovern

In India, genotype 3 and 1 are prevalent...The treatment for G1 is is triple therapy with pegylated interferon, ribavirin, and a protease inhibitor (eg, telaprevir or boceprevir)...The treatment for G3 is dual treatment with pegIFN plus ribavirin....

G3 is relatively easy to treat with great response rates with dual therapy.

Now we see great response rates with G1 as well because of these new HCV protease inhibitors.

As for HIV/HCV....preliminary data with triple therapy looks really promising with great early response rates. We will know in 2012 if the triple therapy leads to viral cure of HCV.

hepatitis B vaccination

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint